Lobsor Pharmaceuticals Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
1
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Lobsor Pharmaceuticals General Information
Description
Manufacturer of pharmaceutical infusion systems designed for managing symptoms of advanced neurological conditions. The company's technology utilizes a combination gel formulation delivered through a lightweight wearable pump directly into the small intestine to increase medication bioavailability and bypass gastrointestinal absorption barriers, enabling individuals with motor fluctuations to achieve stable therapeutic outcomes with reduced drug doses while enhancing overall mobility and daily activity management.
Contact Information
Website
www.lobsor.com(Operating Subsidiary)
Corporate Office
- Kålsängsgränd 10 D
- 753 19 Uppsala
- Sweden
Corporate Office
- Kålsängsgränd 10 D
- 753 19 Uppsala
- Sweden
Lobsor Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Lobsor Pharmaceuticals Comparisons
Industry
Financing
Details
Lobsor Pharmaceuticals Competitors (1)
One of Lobsor Pharmaceuticals’s competitors is Keapstone Therapeutics, a Venture Capital-Backed company based in Sheffield, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Keapstone Therapeutics | Venture Capital-Backed | Sheffield, United Kingdom |
Lobsor Pharmaceuticals Patents
Lobsor Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019237857-A1 | Continuous administration of pharmaceutical composition for treatment of neurodegenerative disorders | Active | 23-Mar-2018 | ||
| AU-2019237857-B2 | Continuous administration of pharmaceutical composition for treatment of neurodegenerative disorders | Active | 23-Mar-2018 | ||
| EP-3768263-A1 | Continuous administration of pharmaceutical composition for treatment of neurodegenerative disorders | Active | 23-Mar-2018 | ||
| EP-3768263-B1 | Continuous administration of pharmaceutical composition for treatment of neurodegenerative disorders | Active | 23-Mar-2018 | ||
| EP-3768263-C0 | Continuous administration of pharmaceutical composition for treatment of neurodegenerative disorders | Active | 23-Mar-2018 | A61K31/277 |
Lobsor Pharmaceuticals Signals
Lobsor Pharmaceuticals Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Lobsor Holding | Uppsala, Sweden | 2014 |
Lobsor Pharmaceuticals FAQs
-
When was Lobsor Pharmaceuticals founded?
Lobsor Pharmaceuticals was founded in 2013.
-
Where is Lobsor Pharmaceuticals headquartered?
Lobsor Pharmaceuticals is headquartered in Uppsala, Sweden.
-
What is the size of Lobsor Pharmaceuticals?
Lobsor Pharmaceuticals has 1 total employees.
-
What industry is Lobsor Pharmaceuticals in?
Lobsor Pharmaceuticals’s primary industry is Therapeutic Devices.
-
Is Lobsor Pharmaceuticals a private or public company?
Lobsor Pharmaceuticals is a Private company.
-
What is the current valuation of Lobsor Pharmaceuticals?
The current valuation of Lobsor Pharmaceuticals is .
-
What is Lobsor Pharmaceuticals’s current revenue?
The current revenue for Lobsor Pharmaceuticals is .
-
Who are Lobsor Pharmaceuticals’s competitors?
Keapstone Therapeutics is a competitor of Lobsor Pharmaceuticals.
-
When was Lobsor Pharmaceuticals acquired?
Lobsor Pharmaceuticals was acquired on 01-Sep-2020.
-
Who acquired Lobsor Pharmaceuticals?
Lobsor Pharmaceuticals was acquired by STADA Arzneimittel.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process